Predictors of treatment outcomes following treat-and-extend regimen with aflibercept for branch retinal vein occlusion: post-hoc analysis of the PLATON trial
Abstract We investigated predictors of visual outcomes and injection interval in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) treated with a treat-and-extend (TAE) regimen. All 48 patients in a multicenter study were followed for 52 weeks and received three monthly intravitre...
Main Authors: | Wonyung Son, Woo Jin Jeong, Jung Min Park, Jung-Yeul Kim, Yong-Sok Ji, Min Sagong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-38955-4 |
Similar Items
-
Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
by: Imoro Z Braimah, et al.
Published: (2019-01-01) -
Aflibercept for macular edema after branch retinal vein occlusion
by: Mahmoud Abouhussein
Published: (2018-01-01) -
Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study
by: Yusuke Arai, et al.
Published: (2020-07-01) -
Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion: 2-Year Prospective Study Outcomes
by: Yusuke Arai, et al.
Published: (2021-07-01) -
Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
by: Yoshihito Sakanishi, et al.
Published: (2021-06-01)